glp-1 odchudzanie Właściwości lecznicze analogów GLP-1. Semaglutyd czy tirzepatyd nie tylko na cukrzycę czy otyłość GLP-1 do odchudzania - zagrożenia

PMID: 35002520 Cell Death Discov Pregnane X receptor protects against age-related bone loss in males via PI3K/Akt-mediated inhibition of apoptosis

Rani Therapeutics oral RT-114 achieved over 150% systemic exposure versus matched subcutaneous dosing in a Phase 1 obesity study with favorable safety

Recent groundbreaking research has revealed a profound paradox regarding glutathione levels in chronic illness

Suggested use: Take 2 capsules in a day with 2 dcl of water (preferably 30 min before meal)

Therapy with peptide BPC-157, which shows nephroprotective action, involves reducing proteinuria while preserving glomerular filtration function due to simultaneous dilation of the afferent and efferent arterioles, which prevents an increase in intraglomerular pressure and disturbances in glomerular autoregulation